Diane Webber, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 851 Commerce Blvd, Suite 107, Dickson City, PA 18519 Phone: 570-489-5561 Fax: 570-489-5563 |
Ms. Stephanie Kubelus Charles, M.S. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 542 Boulevard Ave, Dickson City, PA 18519 Phone: 610-746-1900 |
Kaycee Crofton, DPT Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 542 Boulevard Ave, Dickson City, PA 18519 Phone: 570-489-5010 Fax: 570-489-5060 |
Gina Lee Phillips, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 829 Lincoln St, Dickson City, PA 18519 Phone: 570-702-6268 |
Mary Christine Vignola-robeson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 542 Boulevard Ave, Dickson City, PA 18519 Phone: 570-489-5010 Fax: 570-489-5060 |
Ms. Patricia Ann King, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 851 Commerce Blvd #107, The Aaron Center, Dickson City, PA 18519 Phone: 570-489-5561 |
Bridget Drust, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 542 Boulevard Ave, Dickson City, PA 18519 Phone: 570-489-5010 Fax: 570-489-5060 |
Katherine Stonikinis Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 542 Boulevard Ave, Dickson City, PA 18519 Phone: 570-489-5010 |
Mrs. Grace Marie Dawgert, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 Viewmont Drive, Dickson City, PA 18519 Phone: 570-587-5437 Fax: 570-346-7450 |
Melissa M. Russini, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 851 Commerce Blvd, Suite 107, Dickson City, PA 18519 Phone: 570-489-5561 Fax: 570-489-5563 |
News Archive
BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.
Feeding America, the nation's largest domestic hunger-relief organization, announced today that ADP(R), a leading provider of business outsourcing solutions, has donated $500,000 to help fight hunger in America.
The Los Angeles Times: "At a time when nearly 7 million Californians are uninsured, state regulators are trying to rein in discount health and dental plans that officials say frequently overstate benefits, offer little if any savings and promise access to doctors who aren't part of the system. Some of the discounters fraudulently market themselves as insurance, while preying on the poor, the elderly and others who urgently need care, officials say. ... Plan executives bristle at such criticism. They say a few bad apples have tarnished an industry that offers reliable - and relatively inexpensive - services.
Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University of Texas MD Anderson Cancer Center suggests Dicer may also serve as a biomarker for breast cancer and possibly open up new avenues for diagnosis and treatment.
Systematic collection of cancer patients' symptoms using computer surveys was linked to less frequent emergency room admissions, longer average chemotherapy adherence, greater quality of life improvements, and improved survival, according to a new randomized, controlled trial spearheaded by a UNC Lineberger Comprehensive Cancer Center researcher.
› Verified 5 days ago